Prediction of vedolizumab treatment outcomes by machine learning
J Biopharm Stat
.
2022 Sep 3;32(5):802-804.
doi: 10.1080/10543406.2022.2065501.
Epub 2022 Jun 28.
Author
Philippe Pinton
1
Affiliation
1
Translational Medicine and Clinical Pharmacology, International PharmaScience Center, Ferring Pharmaceuticals, Copenhagen S, Denmark.
PMID:
35763418
DOI:
10.1080/10543406.2022.2065501
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal, Humanized* / therapeutic use
Humans
Machine Learning*
Treatment Outcome
Substances
Antibodies, Monoclonal, Humanized
vedolizumab